Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / VIVO - Meridian Biosciences says its qPCR mixes can be used in monkeypox molecular tests

VIVO - Meridian Biosciences says its qPCR mixes can be used in monkeypox molecular tests

Meridian Bioscience Inc.
Meridian Bioscience (NASDAQ:VIVO) said that its qPCR master mixes can be used to develop molecular diagnostic tests that can detect monkeypox. The company said its inhibitor-tolerant qPCR master mixes are ideal for the detection of monkeypox. Meridian (VIVO) added that qPCR detection is considered the most rapid, sensitive, and accurate method for viral diagnosis. Seeking Alpha contributor Daniel Jones views Meridian (VIVO) as a hold.

For further details see:

Meridian Biosciences says its qPCR mixes can be used in monkeypox molecular tests
Stock Information
Company Name: Meridian Bioscience Inc.
Stock Symbol: VIVO
Market: NASDAQ
Website: meridianbioscience.com
Menu
VIVO VIVO Quote VIVO Short VIVO News VIVO Articles VIVO Message Board
Get VIVO Alerts

News, Short Squeeze, Breakout and More Instantly...